Citations 2
Tuberculosis in the United States: Medical Consultation Services Provided by 5 Tuberculosis Regional Training and Medical Consultation Centers, 2013–2017
Goswami, Neela D. , Mase, Sundari , Griffith, David E. , Bhavaraju, Rajita, Lardizabal, Alfred , Lauzardo, Michael , Chen, Lisa , Wilson, John , Chappelle, Courtney, Haley, Connie A.
Open Forum Infectious Diseases | April 4, 2019 | Volume: 6 | Issue: 6 | Pages: No page available
Abstract With only 9105 new US tuberculosis (TB) cases reported in 2017, expert consultation is essential for TB care. Data were captured 2013–2017 from consultations by 5 CDC-funded centers, now the TB Centers of Excellence (COEs). 14 586 consultations were provided to TB providers, most related to TB disease and treatment regimens.
Rapid Drug Susceptibility Testing with a Molecular Beacon Assay Is Associated with Earlier Diagnosis and Treatment of Multidrug-Resistant Tuberculosis in California
Banerjee, Ritu , Allen, Jennifer R. , Lin, S.-Y. Grace, Westenhouse, Janice, Desmond, Ed, Schecter, Gisela, Scott, Cheryl, Raftery, Ann, Mase, Sundari , Watt, James, Flood, Jennifer
Journal of Clinical Microbiology | August 12, 2010 | Volume: 48 | Issue: 10 | Pages: 3779-3781
ABSTRACTTo assess the clinical impact of a molecular beacon (MB) assay that detects multidrug-resistant tuberculosis (MDR TB), we retrospectively reviewed records of 127 MDR TB patients with and without MB testing between 2004 and 2007. Use of the MB assay reduced the time to detection and treatment of MDR TB.